期刊文献+

小儿急性细菌性痢疾菌群及药物敏感性动态变化研究 被引量:3

Study of Drug Sensitivity and Bacterial Clump of Children Acute Bacterial Disentary
下载PDF
导出
摘要 目的了解小儿急性细菌性痢疾药物敏感性及菌群变化,指导临床合理用药。方法对9年来经细菌学证实小儿急性细菌性痢疾93例分3个阶段药物敏感性进行比较及菌群分析。结果9年来小儿急性细菌性痢疾病原菌以福氏志贺菌为主,菌群分布无变化,未发现新的菌群。志贺菌对头孢三嗪、头孢噻肟、头孢他啶、头孢哌酮舒巴坦、丁胺卡那霉素、左氧氟沙星保持很高的敏感性。对头孢哌酮敏感性2001-2003年度下降至85.7%,随后升至93.5%。对庆大霉素的敏感性逐渐上升。对氨苄青霉素、复方新诺明、诺氟沙星的敏感性一直很差。结论本地区小儿急性细菌性痢疾病原菌仍以福氏志贺菌为主,未发现新的菌群。治疗小儿急性细菌性痢疾比较安全有效的抗生素是三代头孢菌素,谨慎选用丁胺卡那霉素、左氧氟沙星。 Objective To investigate the change trend of drug - sensitivity and bacterial clump of children acute bacterial dysentery to guide clinical drug usage( rational drug usage in clinical practice). Methods The analysis/variance of bacterial and condition of drug - sensitivity among three different stage in 93 cases of children acute bacterial dysentery were compared with bacteriological identification in the nine years. Results Shigella flexeri was found to be predominant in children acute bacterial dysentery in the nine years. Bacterial clump distribution did not change and new bacterial clump was found. Shigella was high sensitive to Cefriaxone, Cefotaxime, Cefotazidime, Cefoperazone and Sulbactam, and Amikacin, and Levofloxacin. The sensitivity to Cefoperazone descended to 85.7% in 2001 -2003 years and increased to 93.5% in later years. The sensitivity to Amicillin sodium, SMZco and Norfloxcin was consistently lower than others. Conclusion Shigella flexeri continues to be the predominant bacterial clump in children acute bacterial dysentery in the area and new bacterial clump is not found. Third generation cephalosporin is more effective and safe to cure children acute bacterial dysentery. Take cautions about using Amikacin and Levofloxacin.
作者 张帮杰
出处 《医药论坛杂志》 2008年第14期34-35,共2页 Journal of Medical Forum
关键词 儿童 细菌性痢疾 菌群 药物敏感性 Children Shigella Bacterial clump Drug - sensitivity
  • 相关文献

参考文献7

二级参考文献13

  • 1[1]Turner SA,Luck SN,Sakellaris H,et al.Role of attP in integrase-mediated intergration of the shigella resistance locus pathogenicty island of shigella flexneri [J].Antimicrob Agents Chemother,2004,48(3):1028-1031.
  • 2[2]Vasilev V,Japheth R,Yishai R,et al.Antimicrobial resistance of Shigella flexneri serotypes in Israel during a period of three years:2000-2002 [J].Epidemiol Infect,2004,132(6):1049-1054.
  • 3[4]Nuyen TV,Le PV,Le CH,et al.Antibiotic resistance in diarrheagenic Escherichia coli and Shigella strains isolated from children in Hanoi,Vietnam [J].Antimicrob Agents Chemother,2005,49(2):816-819.
  • 4[5]Salam MA,Bennish ML.Antimicrobial therapy for shigellosis [J].Rev Infect Dis,1991,13(Suppl 4):S332-341.
  • 5中华儿科杂志编辑委员会.关于喹诺酮类在儿童中的使用.中华儿科杂志,1996,34(5):358-358.
  • 6胡亚美 江载芳 等 主编.诸福棠实用儿科学(第7版)[M].北京:人民卫生出版社,2002.458~461.
  • 7顾友梅.小儿传染病学[M].北京:人民卫生出版社,1990.118.
  • 8孙殿兴,李仕英,张福广,张立,耿云琴,吕书杰.1986~1995年629株痢疾杆菌菌型分布及药敏调查[J].中华传染病杂志,1997,15(3):172-174. 被引量:42
  • 9陈绍潞.第七讲 喹诺酮类药物药理及在儿科临床的应用[J].中国实用儿科杂志,1999,14(7):433-435. 被引量:16
  • 10曹秀章.160 例小儿细菌性痢疾菌群分布药敏试验及临床意义[J].实用预防医学,1999,6(4):247-248. 被引量:1

共引文献53

同被引文献17

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部